Addiction Biology

Cover image for Vol. 18 Issue 6

November 2013

Volume 18, Issue 6

Pages i–i, 883–1031

  1. Issue Information

    1. Top of page
    2. Issue Information
    3. PERSPECTIVE ARTICLE
    4. MINI-REVIEW
    5. COMMENTARIES
    6. PRECLINICAL STUDIES
    7. CLINICAL TRIAL
    8. HUMAN STUDIES
    9. HUMAN EXPERIMENTAL STUDIES
    10. HUMAN GENETIC STUDY
    11. HUMAN NEUROIMAGING STUDY
    12. HUMAN PHARMACOGENOMIC STUDY
    1. Issue Information (page i)

      Version of Record online: 28 NOV 2013 | DOI: 10.1111/j.1369-1600.2013.00505.x

  2. PERSPECTIVE ARTICLE

    1. Top of page
    2. Issue Information
    3. PERSPECTIVE ARTICLE
    4. MINI-REVIEW
    5. COMMENTARIES
    6. PRECLINICAL STUDIES
    7. CLINICAL TRIAL
    8. HUMAN STUDIES
    9. HUMAN EXPERIMENTAL STUDIES
    10. HUMAN GENETIC STUDY
    11. HUMAN NEUROIMAGING STUDY
    12. HUMAN PHARMACOGENOMIC STUDY
    1. A systems medicine research approach for studying alcohol addiction (pages 883–896)

      Rainer Spanagel, Daniel Durstewitz, Anita Hansson, Andreas Heinz, Falk Kiefer, Georg Köhr, Franziska Matthäus, Markus M. Nöthen, Hamid R. Noori, Klaus Obermayer, Marcella Rietschel, Patrick Schloss, Henrike Scholz, Gunter Schumann, Michael Smolka, Wolfgang Sommer, Valentina Vengeliene, Henrik Walter, Wolfgang Wurst, Uli S. Zimmermann, Addiction GWAS Resource Group, Sven Stringer, Yannick Smits and Eske M. Derks

      Version of Record online: 28 NOV 2013 | DOI: 10.1111/adb.12109

  3. MINI-REVIEW

    1. Top of page
    2. Issue Information
    3. PERSPECTIVE ARTICLE
    4. MINI-REVIEW
    5. COMMENTARIES
    6. PRECLINICAL STUDIES
    7. CLINICAL TRIAL
    8. HUMAN STUDIES
    9. HUMAN EXPERIMENTAL STUDIES
    10. HUMAN GENETIC STUDY
    11. HUMAN NEUROIMAGING STUDY
    12. HUMAN PHARMACOGENOMIC STUDY
  4. COMMENTARIES

    1. Top of page
    2. Issue Information
    3. PERSPECTIVE ARTICLE
    4. MINI-REVIEW
    5. COMMENTARIES
    6. PRECLINICAL STUDIES
    7. CLINICAL TRIAL
    8. HUMAN STUDIES
    9. HUMAN EXPERIMENTAL STUDIES
    10. HUMAN GENETIC STUDY
    11. HUMAN NEUROIMAGING STUDY
    12. HUMAN PHARMACOGENOMIC STUDY
  5. PRECLINICAL STUDIES

    1. Top of page
    2. Issue Information
    3. PERSPECTIVE ARTICLE
    4. MINI-REVIEW
    5. COMMENTARIES
    6. PRECLINICAL STUDIES
    7. CLINICAL TRIAL
    8. HUMAN STUDIES
    9. HUMAN EXPERIMENTAL STUDIES
    10. HUMAN GENETIC STUDY
    11. HUMAN NEUROIMAGING STUDY
    12. HUMAN PHARMACOGENOMIC STUDY
    1. Cannabinoid-1 receptor antagonist rimonabant (SR141716) increases striatal dopamine D2 receptor availability (pages 908–911)

      Cleo L. Crunelle, Elsmarieke van de Giessen, Sybille Schulz, Louk J. M. J. Vanderschuren, Kora de Bruin, Wim van den Brink and Jan Booij

      Version of Record online: 29 SEP 2011 | DOI: 10.1111/j.1369-1600.2011.00369.x

    2. Nicotine reinforcement is reduced by cannabinoid CB1 receptor blockade in the ventral tegmental area (pages 930–936)

      Amelie Simonnet, Martine Cador and Stephanie Caille

      Version of Record online: 11 JUL 2012 | DOI: 10.1111/j.1369-1600.2012.00476.x

  6. CLINICAL TRIAL

    1. Top of page
    2. Issue Information
    3. PERSPECTIVE ARTICLE
    4. MINI-REVIEW
    5. COMMENTARIES
    6. PRECLINICAL STUDIES
    7. CLINICAL TRIAL
    8. HUMAN STUDIES
    9. HUMAN EXPERIMENTAL STUDIES
    10. HUMAN GENETIC STUDY
    11. HUMAN NEUROIMAGING STUDY
    12. HUMAN PHARMACOGENOMIC STUDY
    1. Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study (pages 937–946)

      Karl Mann, Tagrid Lemenager, Sabine Hoffmann, Iris Reinhard, Derik Hermann, Anil Batra, Michael Berner, Norbert Wodarz, Andreas Heinz, Michael N. Smolka, Ulrich S. Zimmermann, Stefan Wellek, Falk Kiefer, Raymond F. Anton and The PREDICT Study Team

      Version of Record online: 12 DEC 2012 | DOI: 10.1111/adb.12012

  7. HUMAN STUDIES

    1. Top of page
    2. Issue Information
    3. PERSPECTIVE ARTICLE
    4. MINI-REVIEW
    5. COMMENTARIES
    6. PRECLINICAL STUDIES
    7. CLINICAL TRIAL
    8. HUMAN STUDIES
    9. HUMAN EXPERIMENTAL STUDIES
    10. HUMAN GENETIC STUDY
    11. HUMAN NEUROIMAGING STUDY
    12. HUMAN PHARMACOGENOMIC STUDY
    1. Early smoking onset may promise initial pleasurable sensations and later addiction (pages 947–954)

      Arlette F. Buchmann, Dorothea Blomeyer, Christine Jennen-Steinmetz, Martin H. Schmidt, Günter Esser, Tobias Banaschewski and Manfred Laucht

      Version of Record online: 4 OCT 2011 | DOI: 10.1111/j.1369-1600.2011.00377.x

    2. Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: impact of psychiatric co-morbidity (pages 955–969)

      Francisco Javier Pavón, Pedro Araos, Antoni Pastor, Montserrat Calado, María Pedraz, Rafael Campos-Cloute, Juan Jesús Ruiz, Antonia Serrano, Eduardo Blanco, Patricia Rivera, Juan Suárez, Miguel Romero-Cuevas, Mitona Pujadas, Esperanza Vergara-Moragues, Isolde Gornemann, Marta Torrens, Rafael de la Torre and Fernando Rodríguez de Fonseca

      Version of Record online: 14 NOV 2013 | DOI: 10.1111/adb.12107

    3. Diminished error-related brain activity as a promising endophenotype for substance-use disorders: evidence from high-risk offspring (pages 970–984)

      Anja S. Euser, Brittany E. Evans, Kirstin Greaves-Lord, Anja C. Huizink and Ingmar H. A. Franken

      Version of Record online: 12 NOV 2012 | DOI: 10.1111/adb.12002

  8. HUMAN EXPERIMENTAL STUDIES

    1. Top of page
    2. Issue Information
    3. PERSPECTIVE ARTICLE
    4. MINI-REVIEW
    5. COMMENTARIES
    6. PRECLINICAL STUDIES
    7. CLINICAL TRIAL
    8. HUMAN STUDIES
    9. HUMAN EXPERIMENTAL STUDIES
    10. HUMAN GENETIC STUDY
    11. HUMAN NEUROIMAGING STUDY
    12. HUMAN PHARMACOGENOMIC STUDY
    1. A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers (pages 993–1002)

      Ziva D. Cooper, Richard W. Foltin, Carl L. Hart, Suzanne K. Vosburg, Sandra D. Comer and Margaret Haney

      Version of Record online: 28 JUN 2012 | DOI: 10.1111/j.1369-1600.2012.00461.x

  9. HUMAN GENETIC STUDY

    1. Top of page
    2. Issue Information
    3. PERSPECTIVE ARTICLE
    4. MINI-REVIEW
    5. COMMENTARIES
    6. PRECLINICAL STUDIES
    7. CLINICAL TRIAL
    8. HUMAN STUDIES
    9. HUMAN EXPERIMENTAL STUDIES
    10. HUMAN GENETIC STUDY
    11. HUMAN NEUROIMAGING STUDY
    12. HUMAN PHARMACOGENOMIC STUDY
    1. Dual growth of adolescent smoking and drinking: evidence for an interaction between the mu-opioid receptor (OPRM1) A118G polymorphism and sex (pages 1003–1012)

      Marloes Kleinjan, Evelien A. Poelen, Rutger C. M. E. Engels and Maaike Verhagen

      Version of Record online: 19 JAN 2012 | DOI: 10.1111/j.1369-1600.2011.00422.x

  10. HUMAN NEUROIMAGING STUDY

    1. Top of page
    2. Issue Information
    3. PERSPECTIVE ARTICLE
    4. MINI-REVIEW
    5. COMMENTARIES
    6. PRECLINICAL STUDIES
    7. CLINICAL TRIAL
    8. HUMAN STUDIES
    9. HUMAN EXPERIMENTAL STUDIES
    10. HUMAN GENETIC STUDY
    11. HUMAN NEUROIMAGING STUDY
    12. HUMAN PHARMACOGENOMIC STUDY
    1. Individual differences in decision making and reward processing predict changes in cannabis use: a prospective functional magnetic resonance imaging study (pages 1013–1023)

      Janna Cousijn, Reinout W. Wiers, K. Richard Ridderinkhof, Wim van den Brink, Dick J. Veltman, Linda J. Porrino and Anna E. Goudriaan

      Version of Record online: 21 SEP 2012 | DOI: 10.1111/j.1369-1600.2012.00498.x

  11. HUMAN PHARMACOGENOMIC STUDY

    1. Top of page
    2. Issue Information
    3. PERSPECTIVE ARTICLE
    4. MINI-REVIEW
    5. COMMENTARIES
    6. PRECLINICAL STUDIES
    7. CLINICAL TRIAL
    8. HUMAN STUDIES
    9. HUMAN EXPERIMENTAL STUDIES
    10. HUMAN GENETIC STUDY
    11. HUMAN NEUROIMAGING STUDY
    12. HUMAN PHARMACOGENOMIC STUDY
    1. 5-HTTLPR genotype and daily negative mood moderate the effects of sertraline on drinking intensity (pages 1024–1031)

      Henry R. Kranzler, Stephen Armeli, Howard Tennen and Jonathan Covault

      Version of Record online: 12 NOV 2012 | DOI: 10.1111/adb.12007

SEARCH

SEARCH BY CITATION